Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For CMSA
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 37.34 1.35 0.98
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -0.69 19.16 19.29
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.58 26.80 25.63
Cash 276.61 2.90 0.77
Capex -21.06 -2.07 2.62
Free Cash Flow -71.04 1.16 3.99
Revenue 10.80 7.34 6.62
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -39.00 0.26 0.43
Operating Margin -9.06 0.19 0.21
ROA -8.17 < 0.005 < 0.005
ROE -11.82 0.04 0.04
ROIC 2.77 0.01 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of CMSA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of CMSA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of CMSA is permitted for members.